Farb Daniel Stuart 4
4 · PharmaCyte Biotech, Inc. · Filed Dec 30, 2022
Insider Transaction Report
Form 4
Farb Daniel Stuart
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-12-28+125,000→ 125,000 totalExercise: $2.97From: 2022-12-28Exp: 2032-11-14→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the "2022 Plan"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022.